A recent study conducted by a team from Yale University’s School of Medicine has shed light on the complexities of aging and the various methods employed to potentially slow down this inevitable process. The investigation focused on the effectiveness of lifestyle changes such as diet and exercise, but it also examined the impact of certain medications on biological aging markers.
The study analyzed 51 different human trials, exploring the interplay of diet, physical activity, and pharmacological interventions in relation to aging indicators. The findings were published in August 2026 in the journal *Nature Medicine*.
The challenge of proving that a particular method extends life often necessitates long-term tracking over many years. In an innovative approach, scientists are utilizing a tool known as the “epigenetic clock” to more rapidly observe age-related changes within the body. This tool evaluates chemical markers on a person’s DNA, which alter as aging progresses, allowing researchers to estimate what is referred to as a person’s “biological age.”
The Yale research team assessed a total of 111 DNA methylation biomarkers, including 16 major epigenetic clocks. They closely monitored these markers before and after various interventions, which included different dietary regimes, exercise regimens, medications like metformin—which is used for controlling blood sugar levels—and semaglutide, a drug prescribed for diabetes and obesity. Other interventions examined included anti-TNF therapy, which is primarily used for treating various inflammatory diseases, as well as surgical options for weight loss.
The study suggested that combining a healthy diet with regular exercise could positively influence biological aging markers in some trial participants. The dietary approaches considered varied widely. For instance, the Mediterranean diet predominantly includes vegetables, fruits, whole grains, legumes, and olive oil. Conversely, low-fat diets focus on reducing fat intake, while low-carbohydrate diets aim to minimize the proportion of carbohydrates consumed.
Despite the differences among these dietary strategies, research indicated that when these diets were integrated with physical activity, there appeared to be improvements in aging markers across various studies.
For the general public, this conveys a reassuring message: there is no need to invest in expensive anti-aging products. Adjustments to diet and maintaining an active lifestyle may likely lead to favorable outcomes regarding aging indicators.
The examination of pharmacological interventions within the study highlighted the use of anti-TNF therapy, metformin, and semaglutide. While some changes in aging indicators were noted following the use of these medications, the research underscored the original purpose of these drugs, which was to manage diseases rather than to slow aging. Therefore, any observed changes could be more accurately attributed to the control of the underlying health issues rather than a direct effect on aging.
Additionally, the research also explored drugs aimed at eliminating senescent cells—those that have stopped normal division yet continue to impact surrounding tissues. However, findings related to these drugs varied across different studies, hinting at the complexity of this field of research.
A key discovery from the Yale study was the comparative effectiveness of various testing methods. Researchers found that certain newer forms of epigenetic clocks, designed to assess mortality risk or aging pace, demonstrated more pronounced reactions to interventions, and exhibited a higher degree of consistency in results across different tools.
This implies that the choice of testing method in future studies on anti-aging therapies could significantly affect researchers’ ability to detect relevant changes. Raghav Sehgal, the study’s lead author, noted that previous limitations in data availability made it challenging for scientists to ascertain whether these biological markers could consistently reflect changes following interventions. This new research offers a framework for evaluating anti-aging therapies moving forward.
Albert Higgins-Chen, a senior author of the study and assistant professor of psychiatry at Yale, cautioned that just because biological indicators move in a “younger” direction, it does not automatically confirm that the intervention effectively slows aging, prevents diseases, or extends lifespan. The fundamental question remains: what do these changes imply for the risk of age-related diseases and functional decline in the future? Currently, there are no definitive answers.
For those contemplating anti-aging strategies, it may be more prudent to focus on enhancing dietary and physical activity habits rather than rushing to purchase “youth-restoring” products. Inquiring about the legitimacy of claims made by these products—such as whether any human studies have been conducted and which specific markers have been shown to improve—can serve as a sensible approach before investing in them.